Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Genome-wide DNA methylation profiles of human hepatocellular carcinoma
PubMed Full text in PMC Similar studies Analyze with GEO2R
Epigenome analysis of HCC samples with paired adjacent tissue
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma
PubMed Similar studies Analyze with GEO2R
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma (MeDIP)
Integrative array-based approach identifies MZB1 as a frequently methylated putative tumor-suppressor in hepatocellular carcinoma (expression)
Expression profiling of HCC
Genome-wide DNA methylation analysis in hepatocellular carcinoma
The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes
PubMed Full text in PMC Similar studies SRA Run Selector
Gene expression profiling in liver normal and tumor tissues in C3H mice
Gene expression profiling in Hepa1c1c7 transfected Mst1r or Slpi
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma Cells
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma Cells [methylation]
Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor SGI-110 in Hepatocellular Carcinoma Cells [gene expression]
Epigenetic reactivation of tumor suppressor genes with CRISPRa technologies as precision therapy for hepatocellular carcinoma
PubMed Full text in PMC Similar studies
Re-expression of fetal IGF2 as a target for hepatocellular carcinoma therapy
DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma
Epigenome analysis of cirrhosis and dysplastic liver samples
Applied Biosystems Human TaqMan Low Density Array (TLDA) in HCC tumor and adjacent non-tumor tissues
Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips
Heterogeneity of gene-expression profiles of hepatocellular carcinoma tumors
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on